We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+12.85%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$525B
AUM Growth
+$44.8B
Cap. Flow
-$15.7B
Cap. Flow %
-2.98%
Top 10 Hldgs %
23.82%
Holding
13,823
New
1,903
Increased
5,066
Reduced
5,122
Closed
1,577

Sector Composition

Rank Sector Weight
1 Technology 2.06%
2 Consumer Discretionary 1.41%
3 Healthcare 0.83%
4 Financials 0.79%
5 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RJET
11726
CALL
Republic Airways Holdings
RJET
$869M
$41.7K ﹤0.01%
2,753
-94
-3% -$1.12K
AHT
11727
PUT
Ashford Hospitality Trust
AHT
$21.6M
$41.7K ﹤0.01%
2,150
-1,340
-38% -$29.5K
CRDF icon
11728
PUT
Cardiff Oncology
CRDF
$76.6M
$41.4K ﹤0.01%
28,000
-19,500
-41% -$23.6K
RXT icon
11729
CALL
Rackspace Technology
RXT
$867M
$41.4K ﹤0.01%
20,700
-95,800
-82% -$145K
OCGN icon
11730
PUT
Ocugen
OCGN
$478M
$41.1K ﹤0.01%
70,900
-13,200
-16% -$5.29K
ADVM
11731
CALL
DELISTED
Adverum Biotechnologies
ADVM
$41K ﹤0.01%
5,470
TURN
11732
CALL
DELISTED
180 Degree Capital
TURN
$41K ﹤0.01%
10,000
-12,700
-56% -$49.8K
VATE icon
11733
INNOVATE Corp
VATE
$104M
$40.9K ﹤0.01%
3,327
+199
+6% +$2.44K
ONCY
11734
Oncolytics Biotech
ONCY
$109M
$40.9K ﹤0.01%
+30,306
New +$47.4K
NEPH icon
11735
Nephros
NEPH
$44M
$40.7K ﹤0.01%
+11,784
New +$25.6K
CBIO
11736
PUT
Crescent Biopharma
CBIO
$669M
$40.6K ﹤0.01%
172
-35
-17% -$5.44K
ALLO icon
11737
PUT
Allogene Therapeutics
ALLO
$705M
$40.4K ﹤0.01%
+12,600
New +$35.7K
ACXP icon
11738
PUT
Acurx Pharmaceuticals
ACXP
$6.15M
$40.2K ﹤0.01%
+525
New +$39.6K
AMPE
11739
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$40.1K ﹤0.01%
+19,580
New +$50.7K
YRD
11740
Yiren Digital
YRD
$91.9M
$39.8K ﹤0.01%
12,762
-373
-3% -$978
AREN icon
11741
CALL
Arena Group
AREN
$43.7M
$39.7K ﹤0.01%
+16,700
New +$55.1K
IMA
11742
ImageneBio Inc
IMA
$61.6M
$39.7K ﹤0.01%
+1,681
New +$54.8K
PMVP icon
11743
PUT
PMV Pharmaceuticals
PMVP
$70M
$39.7K ﹤0.01%
12,800
-241,400
-95% -$639K
SOL
11744
CALL
DELISTED
Emeren Group
SOL
$39.6K ﹤0.01%
+14,500
New +$38.3K
TUYA
11745
Tuya Inc
TUYA
$1.12B
$39.6K ﹤0.01%
+17,197
New +$31.8K
RAIL icon
11746
PUT
FreightCar America
RAIL
$238M
$39.4K ﹤0.01%
14,600
+2,000
+16% +$5.05K
CMCT
11747
PUT
Creative Media & Community Trust
CMCT
$12M
0
HUMA icon
11748
PUT
Humacyte
HUMA
$189M
$38.9K ﹤0.01%
13,700
-8,900
-39% -$22.8K
NINE
11749
PUT
DELISTED
Nine Energy Service
NINE
$38.9K ﹤0.01%
14,500
-1,900
-12% -$5.5K
ENIC icon
11750
Enel Chile
ENIC
$6.18B
$38.7K ﹤0.01%
11,957
-986
-8% -$3.07K

Similar funds

Jeff Yass's Q4 2023 Portfolio in Review

As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
  • Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
  • Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
  • Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
  • Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
  • Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
  • Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.